Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Sandmann S, Unger T
L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil
Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201

PDF    Summary    Overview   

First Image Fig. 6: Kalziumkanal - Mibefradil Fig. 7: Kalziumkanal - Mibefradil Fig. 8A-B: Kalziumkanal - Mibefradil Fig. 9: Kalziumkanal - Mibefradil Fig. 10: Kalziumkanal - Mibefradil Fig. 11: Kalziumkanal - Mibefradil Fig. 12: Kalziumkanal - Mibefradil This Image - Fig. 13: Kalziumkanal - Mibefradil
Figure/Graphic 13: Kalziumkanal - Mibefradil
Bar graph showing changes in the number and duration of silent ischaemia events with mibefradil treatment. A significant linear dose-response relation is shown across all treatment groups for ischaemic events and ischaemia duration, p < 0.001.
 
Kalziumkanal - Mibefradil
Previous Image Next Image  


Figure/Graphic 13: Kalziumkanal - Mibefradil
Bar graph showing changes in the number and duration of silent ischaemia events with mibefradil treatment. A significant linear dose-response relation is shown across all treatment groups for ischaemic events and ischaemia duration, p < 0.001.
 
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung